Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Bristol-Myers Squibb Leads Biopharma Recovery With Almost 25% Growth In Market Cap, But Novo Nordisk And Lilly Suffer Market Setbacks
November 08, 2024
Tickers
ABBV
ALNY
BMY
GILD
Tags
Large Cap
News
SNY
From
Benzinga
Why Alphabet Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
October 30, 2024
Tickers
AMBO
AMD
DBGI
DJT
Tags
Pre/Market Outlook
GOOG
Trading Ideas
From
Benzinga
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
Tickers
AMGN
AZN
CTLT
GPCR
Tags
VKTX
AZN
Eurozone
From
Benzinga
Jazz Pharmaceuticals' Zepzelca/Tecentriq Combo Regimen Can Potentially Delay Disease Progression, Extend Survival In Aggressive Form Of Lung Cancer
October 15, 2024
Tickers
JAZZ
NEWS
RHHBY
Tags
Market News
why it's moving
RHHBY
From
Benzinga
Novo Nordisk, Eli Lilly Could Face Downward Pressure Despite Market Dominance From Potentially 16 New Obesity Drugs: See The Names
October 11, 2024
Tickers
ALT
AMGN
LLY
NEWS
Tags
News
AMGN
NVO
From
Benzinga
Why Is Cancer Focused Tempest Therapeutics Stock Trading Higher On Thursday?
October 10, 2024
Tickers
NEWS
RHHBY
TPST
Tags
Stories That Matter
Benzinga
Movers
From
Benzinga
Nano-Cap Bio-Path Takes Plunge In Weight Loss Race, Initiates Obesity Program With Drug Candidate Under Development For Blood Cancer
October 08, 2024
Tickers
ABBV
BPTH
NEWS
RHHBY
Tags
General
Biotech
Movers
From
Benzinga
Scholar Rock's Muscle Wasting Drug Excels In Pivotal Trial, Plans FDA Submission Next Year
October 07, 2024
Tickers
BIIB
NEWS
RHHBY
SRRK
Tags
Top Stories
SRRK
Trading Ideas
From
Benzinga
2 Artificial Intelligence Stocks That Could Deliver Explosive Gains
October 07, 2024
Tickers
RHHBY
RXRX
SNY
SOUN
Tags
BAYR/Y
Market News
SOUN
From
Motley Fool
Economist Justin Wolfers Points To Obesity Rate Decline As Ozempic And Wegovy Spur Historic Shift In Fight Against Obesity — Has US Reached A Turning Point?
October 06, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
LLY
Health Care
NVO
From
Benzinga
3 Top Stocks That Could Still Rocket Higher in 2024
October 04, 2024
Tickers
BBIO
PFE
PTCT
RHHBY
Tags
PFE
Recent Press Releases
VRTX
From
Motley Fool
Roche Fast-Tracks Obesity Drug Development, Eyes Over $3B Sales Potential
September 30, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
Briefs
Biotech
Stories That Matter
From
Benzinga
Roche's Antiviral Drug Reduces Transmission Of Influenza Viruses, Late-Stage Study Shows
September 19, 2024
Tickers
NEWS
RHHBY
Tags
News
Large Cap
Health Care
From
Benzinga
1 Telemedicine Stock I Wouldn't Touch With a 10-Foot Pole (Hint: It's Not Teladoc)
September 17, 2024
Tickers
ALT
AMZN
HIMS
LLY
Tags
NVO
LLY
Recent Press Releases
From
Motley Fool
Back-To-Back FDA Approvals For Roche's Two Under-The-Skin Injections
September 16, 2024
Tickers
NEWS
RHHBY
Tags
FDA
General
Biotech
From
Benzinga
Viking Therapeutics: A Bad Result for Roche's Weight-Management Pill Is Great News for Oral VK2735
September 13, 2024
Tickers
RHHBY
VKTX
Tags
Market News
Recent Press Releases
VKTX
From
Motley Fool
Why Roche Holdings Stock Withered on Wednesday
September 11, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
Market News
Recent Press Releases
From
Motley Fool
Fulcrum Therapeutics Upgraded: BofA Debates Pivotal Study Success For Losmapimod In Rare Genetic Muscle Disease
September 09, 2024
Tickers
FULC
NEWS
RHHBY
RNA
Tags
FULC
RNA
Price Target
From
Benzinga
Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst
September 09, 2024
Tickers
AZN
BMY
ELVN
NEWS
Tags
Market News
NVS
why it's moving
From
Benzinga
Moderna And BioNTech Bet On Personalized Cancer Vaccines To Revive Fortunes After Dwindling COVID-19 Vaccine Sales
August 29, 2024
Tickers
BNTX
MRK
MRNA
NEWS
Tags
BNTX
MRNA
Market News
From
Benzinga
Diagnostic Giants Labcorp, Roche To Ramp Up Testing Capacity Amid Global Concerns Over New Mpox Strain
August 26, 2024
Tickers
ABT
BVNKF
BVNRY
DGX
Tags
DGX
BVNRY
Briefs
From
Benzinga
Novo Nordisk and Eli Lilly Could Have a Big Rival in the GLP-1 Market in a Few Years
August 18, 2024
Tickers
LLY
NVO
RHHBY
Tags
RHHBY
NVO
LLY
From
Motley Fool
Roche Misses Out On Weight-Loss Blockbuster Drug, Now Playing Catch-Up In Booming Market
August 16, 2024
Tickers
LLY
NEWS
NVO
RHHBY
Tags
General
Media
Briefs
From
Benzinga
Why Is Small-Cap Tempest Therapeutics Stock Trading Higher On Thursday?
August 15, 2024
Tickers
NEWS
RHHBY
TPST
Tags
Market News
RHHBY
why it's moving
From
Benzinga
Prediction: This Company Will Disrupt Eli Lilly and Novo Nordisk in the Weight Loss Market (Hint: It's Not Pfizer)
August 15, 2024
Tickers
LLY
NVO
RHHBY
Tags
LLY
NVO
Recent Press Releases
From
Motley Fool
Cancer-Focused Syros Pharmaceuticals Stops Mid-Stage Leukemia Combo Therapy Study, Cites Disappointing Unexpected Outcome
August 13, 2024
Tickers
ABBV
BMY
NEWS
RHHBY
Tags
ABBV
Health Care
Top Stories
From
Benzinga
Merck Stops Lung Cancer Study For Keytruda Combo Due To Ineffective Results, Side Effects
August 08, 2024
Tickers
MRK
NEWS
RHHBY
Tags
General
RHHBY
MRK
From
Benzinga
Here's Why Eli Lilly Stock Dropped 12% Last Month
August 08, 2024
Tickers
AMGN
LLY
NVO
PFE
Tags
PFE
Recent Press Releases
NVO
From
Motley Fool
Roche Considers Selling Cancer Data Specialist Flatiron Health Business, Highlights Challenges With Start-Up Acquisitions
August 07, 2024
Tickers
C
GOOG
GOOGL
NEWS
Tags
RHHBY
Market News
M&A
From
Benzinga
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
August 05, 2024
Tickers
AGEN
BMY
MRK
NEWS
Tags
Health Care
Top Stories
News
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.